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Sexual steroids regulate the secretion of pituitary trop hormones acting directly on the pituitary gland and through the central 
nervous system by feed-back mechanisms. Estrogen and progesterone receptors were identified on various pituitary hormone 
secreting cells and in several hypothalamic and extrahypothalamic structures. In the clinical practice long term estrogen treat-
ment is frequently applied in both male and female patients. The aim of our experiment was to study the effect of concomitant 
progesterone (P) administration on changes caused by long term estrogen treatment in the secretion of LH. FSH. PRL . ACTH 
and on the changes of S-100 (present in folliculostellate cells) immunoreactivity tested by R IA and immunohistochemistry 
in Sprague-Dawley male and female rats. Estrogen (diethylstilbestrol. DES) P or both in a silastic capsule were implanted 
under the skin of 25 day-old rats. The survival of animals were two months. The animals were decapitated in the morning, 
trunk blood was used for R IA and the anterior pituitary for immunohistochemistry. We have also studied whether the changed 
hormone secretion caused by DES can return to normal level l or 2 months after the removal of DES containing capsule. The 
following results were obtained. In the vaginal smear of female rats upon DES treatment persistent estrus was observed. DES+P 
did not interrupt the cyclicity but it was irregular and metestrus predominated. P alone had no effect. LH: DES depressed the 
basal level of LH in both female and male rats, and P did not modify the effect of DES. It was more pronounced in female 
than in male rats. FSH: DES and DES+P very moderately influenced the basal level of FSH in female rats and both treatment 
depressed it in male rats. PRL: DES dramatically enhanced the PRL levels and the effect of DES+P was much lower than that 
of DES alone. P did not influence the effect of treatments, in both female and male rats it showed similar tendency. ACTH: 
Effect of various treatment on ACTH plasma levels was very similar to their effect on the PRL levels. DES enhanced the 
ACTH level in both sexes. P blunted this effect. P alone did not influence the ACTH level. Immunohistochemistry supported 
the abovementioned results. The number of LH and FSH immunoreactive cells decreased in the anterior pituitary, the changes 
in the ACTH immunoreactivity was not striking, the number and the size of PRL immunoreactive cells extremly increased, 
they formed prolactinomas. The distribution of S-IOO immunoreactive folliculostellate cells is characteristic. In intact rats 
these cells were evenly distributed and they formed a barrier at the border of anterior and intermediate lobes. In DES treated 
rats this distribution is modified. Folliculostellate cells were hardly observed inside the prolactinomas; however, these cells 
demarcated the prolactinomas. The effect of removal of DES capsule on the plasma hormone levels: The removal of DES 
capsule 2 months after implantation gradually restored the changed LH. FSH and PRL levels by the end of the succeeding 2 
month survival time. Two months after removal we had results similar to the intact aged matched controls. ACTH remained 
higher in female rats, and in male rats it was much higher I month after removal and returned to intact level 2 months later. 
On the basis of the abovementioned results it was concluded that I. There is sexual dimorphism in the responsiveness of 
gonadotropes and corticotropes to steroid treatment. 2. P blunted the enhancing effect of DES on the PRL and ACTH levels. 
However, its effect on the case of LH and FSH was not significant. 3. After the removal of DES its effect is partially restored. 
LH. FSH and PRL returned to intact level: however. ACTH remained higher by the end of 2 month survival time. 
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